All Stories

  1. Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT)

    Article • European Journal of Cancer, May 2025, Elsevier

    Dr Jose Carlos Tapia

  2. The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease

    Article • Cancers, August 2024, MDPI AG

    Dr Jose Carlos Tapia

  3. The FLARE Score and Circulating Neutrophils in Patients with Cancer and COVID-19 Disease.

    Article • July 2024, MDPI AG

    Dr Jose Carlos Tapia

  4. NLR Outperforms Low Hemoglobin and High Platelet Count as Predictive and Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

    Article • Clinical Genitourinary Cancer, June 2024, Elsevier

    Dr Jose Carlos Tapia

  5. Cumulative incidences of hypogonadism, hypertension, and dyslipidaemia in patients with stage I seminoma treated with a risk-adapted strategy: a Spanish single-centre retrospective analysis

    Article • Clinical & Translational Oncology, February 2024, Springer Science + Business Media

    Dr Jose Carlos Tapia

  6. Treatment patterns and survival outcomes before and after access to immune checkpoint inhibitors for patients with metastatic urothelial carcinoma: A single-centre retrospective study from 2004 to 2021.

    Article • Clinical Genitourinary Cancer, February 2024, Elsevier

    Dr Jose Carlos Tapia

  7. Association between control group therapy and magnitude of clinical benefit of cancer drugs

    Article • Scientific Reports, December 2022, Springer Science + Business Media

    Dr Jose Carlos Tapia

  8. 90‐day mortality and clinical outcomes of patients with solid tumours and COVID ‐19 infection during the first pandemic outbreak in Catalonia, Spain: a multicentre retrospective study

    Article • International Journal of Cancer, December 2021, Wiley

    Dr Jose Carlos Tapia

  9. Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period

    Article • Journal of the National Comprehensive Cancer Network, September 2021, Harborside Press, LLC

    Dr Jose Carlos Tapia

  10. Multiple pruritic papules with central black dots on the extremities of a farmworker

    Article • JDDG Journal der Deutschen Dermatologischen Gesellschaft, February 2021, Wiley

    Dr Jose Carlos Tapia

  11. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis

    Article • BMC Infectious Diseases, January 2020, Springer Science + Business Media

    Dr Jose Carlos Tapia

  12. Change in magnitude of clinical benefit, overall survival (OS) and quality of life (QoL) between time of approval and post-marketing among cancer drugs approved by the US Food and Drug Administration (FDA) 2006-2015

    Article • Annals of Oncology, October 2019, Elsevier

    Dr Jose Carlos Tapia

  13. Treatment satisfaction and need for shared decision‐making in patients with psoriasis from Peru

    Article • British Journal of Dermatology, October 2017, Wiley

    Dr Jose Carlos Tapia

  14. Hair follicle as early marker of diabetes?

    Article • Medical Hypotheses, October 2016, Elsevier

    Dr Jose Carlos Tapia

  15. The dream of health information for all

    Article • F1000Research, May 2016, Faculty of 1000, Ltd.

    Dr Jose Carlos Tapia, Dr Alvaro Proaño

  16. The dream of health information for all

    Article • F1000Research, January 2016, Faculty of 1000, Ltd.

    Dr Alvaro Proaño, Dr Jose Carlos Tapia

  17. Dermatological journals available to Latin American dermatologists

    Article • International Journal of Dermatology, October 2015, Wiley

    Dr Jose Carlos Tapia

  18. Soil-transmitted helminth infections in South America

    Article • The Lancet Infectious Diseases, March 2014, Elsevier

    Dr Jose Carlos Tapia